PROJECT: Hera Biomedical Inc. 
(www.herabiomedical.com)

UPDATE: 06-03-2008
After almost 12 months, HERA BIOMEDICAL successfully presented to a very prominent Panel of experts, which included the Head of Research at Amgen Biotech; Head of Incubation at Roche; a Partner at Monitor Ventures; The Head of the promotion office for Heidelberg Germany and a prominent Biotech executive and professor at UC Berkeley. The mentoring of HERA BIOMEDICAL not only took place in San Francisco and the Bay Area but also in Switzerland. After numerous mentoring meetings, HERA has been launched into the fundraising path.

Hera Biomedical, Inc. is a biotech company dedicated to the development and marketing of innovative diagnostics of and therapies for pregnancy disorders. Our initial objective is to develop a diagnostic test for the early detection of pre-eclampsia, a disease that affects over 40% of all pregnancies.

Idea Owner: Fabio Rupp, PhD, Founder & CEO Program Management: Alex Fries

Mentors & Volunteers: Tony Wessling Phillip Stauffer Zuzana Goldstein Robert Rieder Marc Dangeard Michael Muller Ben Perkins Jenny Finchman Pius Kampfen Michael Schuppenhauer Devi Ramanan Ruedi Sandmeier Martina Frank Julie Pearl Peter Matlock

 

PROJECT: S'Art AG 
(www.s-art.ch)

UPDATE: 01-30-2008
SArt has expanded to other Swiss cities in the past 6 months. Further, Susanne Schroetter, CEO of SArt has hired a Chief Operating Officer to handle the increasing business and manage the expansion in Europe.

Susanne will be focusing on the new USA business that has increased since her presentation to the Club Entrepreneur. SArt is also redoing its branding. The company retained a member company from the Swiss American Chamber, The Wessling Creative Group for this job.

UPDATE: 03-22-2007
The SArt project was successfully concluded on March 14th, 2007. The interest from our members to participate and support this project was overwhelming.

SArt AG, a Firm based out of Zurich, Switzerland, providing Classes and Tours in European Fine Arts, needed advise in deciding if it should replicate its very successful business in North America, specifically in California.

After over 40 meetings with various mentors and volunteers, a final presentation was made to a review panel that included experts from the Travel, Legal, Academic and Business Industries. Even more so, we had the honor to have our own Swiss American Chamber CEO, Mr. Martin Naville, as one of the panelists.

Idea Owner Susanne Schroedter, CEO Program Management Alex Fries Bruno Schurter

Mentors & Volunteers Alex Fries Bruno Schurter Robert Rieder Julie Pearl Daniel Hiltebrand Kennith Ebanks Tony Wessling Roger Steiner Gretchen Turner John Maillard James Bridgman Gaby H Burkert Zuzana Goldstein Marc Dangeard Beata C. Lewis Esther Scott Kenneth D. Ebanks

 

PROJECT: COLLANOS, INC. 
(www.collanos.com)

UPDATE: 01-24-2008
Zurich, San Francisco, January 24, 2008 – The third largest Swiss Bank, Zurcher Kantonalbank (ZKB), comes on board as an additional institutional investor in Collanos Software, a Swiss-American start-up. Read Press Release

UPDATE: 04-20-2007
Company has made a lot of progress in all areas. Product version 1.0 was released and thousands of users have downloaded it. A few strategic partnerships have also been closed.

 

UPDATE: 08-14-2006
Successful closure of project. Collanos successfully presented to the Review Board in June. Two Angel Investors decided to invest into the company.

 

UPDATE: 02-16-2006
Collanos, a team collaboration software company, has been selected to be the next project for CE.

Collanos allows dispersed teams to access their shared work spaces locally on their computers, communicate with their colleagues using existing channels, and, using peer-to-peer technology, keep members' work spaces in sync.

The project was officially launched during the kick-off meeting on February 13, 2006 at the Swissnex offices in San Francisco.

The project team is composed of the following Members and Friends of the Chamber (alphabetically):

Idea Owner Franco Dal Molin Gil Heiman Program Management Bruno Schurter Marc Dangeard Pius Kampfen

Mentors & Volunteers Achim Hoelzle Alex Fries Beata C. Lewis Christine Kohl-Zaugg David Musavi Jennifer Marks Jenny Fichmann Jurgen Auerbach Karin Immergluck Max Gygax Philipp Stauffer

 

PROJECT: CANDERIS BIOSCIENCES, INC. 
(www.canderis.com)

UPDATE: 04-20-2007
Canderis Inc, as the company incorporated, was able to secure an important partner to conduct tests. This partner happens to be a member of the Swiss American Chamber of Commerce. The company is still under stealth mode and hence not much information is being provided.

 

UPDATE: 01-18-2005
The CE just completed its very first cycle. The idea selected for evaluation was for a new device in the area of life science diagnostics. This project started on November 1st, 2004 and was presented to the Review Board on January 17, 2005. The project team was composed of the following Members and Friends of the Chamber:

Idea Owner Stephane Follonier, Pierre Indermuehle Program Management Bruno Schurter, Daniel Hiltebrand Program Facilitator Marc Dangeard Volunteers David Musavi Marina Helm Sven Loetscher Maria Pantoja Manfred Heidecker

Review Board James Bridgman, Intellectual Property Peter Craddock, Venture Capital Dick Fredericks, Venture Capital Pius Kampfen, Investment Banking Michael Mueller, Academia Fabio Rupp, Science Robert Rieder, Business & Finance Ruedi Sandmeier, Biotech Ben Perkins, Venture Capital Mentors Philipp Stauffer (Market Study & Business Development) Jennifer Marks (Market Study & Business Development) Michael Fisch (Legal) Alex Fries (Business Development) Andreas Glocker (Financial Planning) Jens Kordetsky (Financial Planning) Pius Kampfen (Fund Raising) Ruedi Sandmeier (12 Magic Slides)

Due to the confidential nature of the project, we apologize for not being able to make the final summary report available on-line.